Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 38/73 ]
NASDAQ | Common Stock
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally.
The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis.
It also develops FemBloc, a non-surgical permanent birth control solution.
The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations.
Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 6, 25 | 0.00 Increased by +100.00% | -0.13 Increased by +100.00% |
| Aug 11, 25 | -0.16 Increased by +23.81% | -0.16 |
| May 8, 25 | -0.23 Decreased by -35.29% | -0.19 Decreased by -21.05% |
| Mar 27, 25 | -0.23 Decreased by -21.05% | -0.19 Decreased by -22.67% |
| Nov 12, 24 | -0.24 Increased by +7.69% | -0.20 Decreased by -20.00% |
| Aug 8, 24 | -0.21 Increased by +4.55% | -0.16 Decreased by -29.23% |
| May 9, 24 | -0.17 Increased by +32.00% | -0.19 Increased by +10.53% |
| Mar 28, 24 | -0.19 Increased by +24.00% | -0.21 Increased by +9.52% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 409.27 K Increased by +84.78% | -4.59 M Increased by +2.11% | Decreased by -1.12 K% Increased by +47.02% |
| Mar 31, 25 | 341.26 K Increased by +25.86% | -5.90 M Decreased by -63.82% | Decreased by -1.73 K% Decreased by -30.16% |
| Dec 31, 24 | 581.58 K Increased by +172.90% | -5.12 M Decreased by -16.17% | Decreased by -881.00% Increased by +57.43% |
| Sep 30, 24 | 554.91 K Increased by +127.09% | -5.41 M Decreased by -35.33% | Decreased by -974.73% Increased by +40.41% |
| Jun 30, 24 | 221.48 K Decreased by -30.90% | -4.68 M Decreased by -61.90% | Decreased by -2.12 K% Decreased by -134.29% |
| Mar 31, 24 | 271.14 K Decreased by -7.77% | -3.60 M Decreased by -22.17% | Decreased by -1.33 K% Decreased by -32.47% |
| Dec 31, 23 | 213.11 K Decreased by -9.02% | -4.41 M Decreased by -52.39% | Decreased by -2.07 K% Decreased by -67.50% |
| Sep 30, 23 | 244.36 K Decreased by -29.67% | -4.00 M Decreased by -37.42% | Decreased by -1.64 K% Decreased by -95.40% |